trans-4-(3,4,5-Trifluorophenyl)-trans-4'-propylbicyclohexane, 98%, 5g

3-chloro-N-(4-methoxy-2-methylphenyl)propanamide, 95.0%, 5g

Benzoic acid, 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]-, 95%, 250mg

5-Bromo-2-(trifluoromethyl)aniline, 98.0%, 1g

7-Amino-5-(4-bromophenyl)-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carbonitrile, 250mg

2-AMINO-2-(TETRAHYDRO-2H-PYRAN-3-YL)ACETIC ACID, 95.0%, 50mg

2-Methyl-6-nitroaniline, 98.0%, 1g

Ethyl 2-bromo-4,5-difluorobenzoate, 95.0%, 25g

1-(6-Bromo-pyridin-2-yl)-azetidine-3-carboxylic acid, 95.0%, 100mg

2,4-Dibromophenoxyacetic acid, 98.0%, 10g

Infinity corrected plan PL-M 20x/0.40 IOS objective. Working distance 7.8 mm. No cover glass correction

[4-(6-ethoxy-1,3-benzothiazol-2-yl)phenyl]amine, 95.0%, 1g

N-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)acetamide, 95.0%, 1g